drugset / Trial / NCT00198471

Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment

NCT00198471 ↗

Phase 2 Completed 10 enrolled Bausch & Lomb Incorporated
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the efficacy of intravitreous injections of Vitrase to induce posterior vitreous detachment(PVD) in subjects with moderate to severe non-proliferative diabetic retinopathy.

Timeline

Start
2005-07
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject HYALURONIDASE (OVINE) Protein / enzyme biologic 75 iu Intravitreal